Jason G. Duncan's most recent trade in Neumora Therapeutics Inc. was a trade of 500,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 500,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 May 2025 | 400,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 Feb 2025 | 400,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neumora Therapeutics Inc. | Jason G. Duncan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |